Fate Therapeutics, Inc. · NASDAQ:FATE

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc. (Schedule 13D/A)

Event Apr 20, 2026 · Filed Apr 22, 2026

Redmile Group, LLC reported a 14.90% stake in Fate Therapeutics, Inc., 18,229,078 shares, with active intent on Apr 20, 2026. Filed Apr 22, 2026 (Schedule 13D/A).

Stake
14.90%
Shares
18,229,078
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Redmile Group, LLC14.90%18,229,078
Jeremy C. Green14.90%18,229,078
RedCo II Offshore SPV LLC8.50%10,144,307
RedCo II Master Fund, L.P.0%0

Source

View original at SEC

Related